Anissa Jabbour completed her PhD in 2005 chatracterising the function of caspase inhibitors and has since undertaken three post-doctoral positions in the field of cell death before starting her own group at the Australian Centre for Blood Diseases (ACBD), Monash University. Dr Jabbour's primary research focus is how cell death and survival signalling cascades are regulated by cytokines, in particular Interleukin-3 (IL-3) and GM-CSF. Her laboratory is interested in how IL-3 and GMCSF signal cell survival and proliferation, and how these survival pathways are deregulated in Acute Myeloid Leukaemia.
Dr Jabbour's postdoctoral research investigated
Dr Jabbour and her teams current primary research focus is to analyse